| Financial Year |
March 31 2023 |
| Monetary Funds |
204,729,246.66 |
| Held-for-trading Financial Assets |
866,612,372.19 |
| Notes Receivable |
-- |
| Accounts Receivable |
37,294,584.33 |
| Advances to Suppliers |
9,919,233.32 |
| Other Receivables |
697,587.18 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
34,176,992.54 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
2,910,184.85 |
| Total Current Assets |
1,156,340,201.07 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
57,815,578.57 |
| Fixed Assetes |
163,288,308.86 |
| Under-construction Projects |
7,526,089.04 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
23,033,845.38 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
20,834,566.18 |
| Deferred Income Tax Assets |
18,591,168.84 |
| Other Non-Current Assets |
5,899,075.57 |
| Sub-Total of Non-Current Assets |
317,583,755.93 |
| Total Assets |
1,473,923,957.00 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
15,799,637.67 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
4,456,902.92 |
| Taxes Payable |
2,098,189.80 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
8,842,519.62 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,111,225.70 |
| Other Current Liabilities |
156,847.58 |
| Sub-Total of Current Liabilities |
51,693,576.01 |
| Long-term Loans |
40,600,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
4,199,911.76 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
79,741,893.01 |
| Total Liabilities |
131,435,469.02 |
| Paid-In Capital(Or Share Stock) |
133,333,334.00 |
| Capital Surplus |
887,733,224.49 |
| Surplus Reserve |
42,384,508.99 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
257,761,513.66 |
| Minority Stockholder's Interest |
21,047,593.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,321,440,894.68 |
| Owner's Equity（Stockholder's Equity） |
1,342,488,487.98 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,473,923,957.00 |
